Baxter Names Robert H. Armstrong Vice President, Research & Development, Medical Devices
Posted on: Tuesday, 6 December 2005, 09:00 CST
DEERFIELD, Ill., Dec. 6 /PRNewswire-FirstCall/ -- Baxter International Inc. announced today the appointment of Robert H. Armstrong to the newly created position of vice president, research and development (R&D), medical devices and adjacent disposables. He will report to Peter Arduini, president of Baxter's Medication Delivery Business, and will be responsible for developing a new R&D Device Center of Excellence, which consolidates engineering and product development activities of multiple device platforms and associated disposables for Baxter's Medication Delivery, Renal and Transfusion Therapies businesses.
"The formation of this important new R&D group and the appointment of a leader with Bob's experience and track record in product development symbolizes our commitment to excellence in medical devices," said Arduini. "With the formation of a device center of excellence, we are investing in innovation and aligning our resources to accelerate the introduction of new products into the marketplace and continue to improve the overall quality of our current device portfolio."
Before joining Baxter on December 1, Armstrong spent over 20 years with GE Healthcare in various positions of increasing responsibility in engineering and product development, most recently as general manager of R&D for CT products, positron emission technology and nuclear medicine. Armstrong earned his MBA from the University of Wisconsin, Milwaukee, and his BS in physics from St. Norbert College in DePere, Wisconsin.
Baxter International Inc., through its subsidiaries, assists healthcare professionals and their patients with treatment of complex medical conditions, including cancer, hemophilia, immune disorders, kidney disease, and trauma. The company applies its expertise in medical devices, pharmaceuticals, and biotechnology to make a meaningful difference in patients' lives.
Baxter International Inc.
CONTACT: Media Contacts, Erin Gardiner, +1-847-948-4210, orCindy Resman, +1-847-948-2815, or Investor Contacts, Mary Kay Ladone,+1-847-948-3371, or Clare Sullivan, +1-847-948-3085, all of BaxterInternational Inc.
Web site: http://www.baxter.com/
Source: PRNewswire-FirstCall
Related Articles
- Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East
- Reliability Solutions CEO, Product Quality Management CEO, and Design Services President Participate in Medical Device Expo and Host Open House
- OCTANe's Medical Device & Investor Forum Highlights Key Trends, Investment Opportunities
- New Database from ANSI, AAMI, ASTM International, and DIN Provides Centralized Source of Information for Medical Device Professionals
- Optimizing Staff Levels to Drive Growth in Medical Device Organizations
- Service Outsourcing Opportunities in Medical Device Market worth US$26.77 Billion by 2014
- Cardio Vascular Medical Device Launches Corporate Website
- Panasonic to Start Development of New Professional 3D Production System
- Perfisans Networks Announces Development of New Wireless Security Product for Wireless Broadband Communications
 |
 |
User Comments (0)
RSS Feeds